Parkinson’s Disease Therapeutics Market

30 Apr


Parkinson’s Disease Therapeutics Market Poised to Grow at a CAGR of 5.8% by 2024

  • By admin

  • January, 1970

Infinium Global Research has added a new report on Parkinson’s Disease Therapeutics Market. The report presents analysis of global as well as regional markets of parkinson’s disease therapeutics market over the period of 2016 to 2024. Parkinson's disease is a long-term degenerative disorder of the nervous system that mainly affects the nerve cells in the brain. The symptoms such as dementia, anxiety, and depression generally come on slowly over time. Other symptoms of this disease are improper motor movements, muscle stiffness, uncontrolled body movement and balance problems.  Presently Parkinson's disease is incurable, only treatments options such as medication and surgery to manage the symptoms are available. Parkinson's disease generally affects the older people who are above 50 years of age and the risk increases with increasing age. The Parkinson's disease treatment is used to control symptoms such as shaking of hands, uncontrolled movement of body, and others. The therapeutic methods like levodopa consolidation with carbidopa are measured as an effective treatment for the symptoms of Parkinson's disease. Another option that is surgical treatment is also available but it is effective for those patients who are previously responded to levodopa therapy.

Some of the major factors driving the growth of this market are rising growth in aged population joined with growing frequency of Parkinson's disease in the developed countries is boosting the growth of the Parkinson’s disease therapeutics market. Furthermore, growing environmental factors and genetic heredity are also facilitating the growth of the market. Furthermore, Upsurge in consciousness regarding Parkinson’s disease and high clinical R&D budget by the governments and non-profit organizations are anticipated to boost the growth of this market over upcoming years. The favorable product pipeline represents the potential development opportunities during the forecast period. On the other hand expiration of patent drugs is projected to hamper the market growth.


Geographically, North America is expected to hold the largest market share in Parkinson’s disease Therapeutics Market followed by Europe and Asia Pacific. Growth in North America region is mainly due to growing spending on healthcare, developed healthcare infrastructure and promising medical compensation policies. As per the Parkinson Association of the Carolinas, nearly 60,000 Americans are diagnosed with Parkinson’s disease each year.  Factors responsible for the growth in Europe region is owing to growing government enterprises for promoting the healthcare sector and augmented adoption of research and development activities in this region. Furthermore, Asia Pacific region is driven by growing numbers of healthcare organizations, growth in geriatric population and growing frequency of Parkinson’s disease. Countries like India, China, and Japan are the key market players in this region for Parkinson’s disease therapeutics market. Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global parkinson’s disease therapeutics market but also make strategic decisions to capture the most lucrative markets in the near future. The market size is presented in terms of value for the historic year 2016 and estimated for forecast period of 2018-2024.



Get 15% discount for early purchase of global parkinson’s disease therapeutics market report by clicking the following link, Use code IGRD15 to request the discount in the given form


The recent report identified that North America dominated the global parkinson’s disease therapeutics market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the parkinson’s disease therapeutics market worldwide.


The report segments the global parkinson’s disease therapeutics market on the basis of Drug Class, Distribution Channel and End User.


Global Parkinson’s  Disease Therapeutics Market by Drug Class

·         Carbidopa/Levodopa

·         Dopamine Receptor Agonists

·         Mao Inhibitors

·         Comt Inhibitors

·         Anticholinergics

·         Other Drugs


Global Parkinson’s Disease Therapeutics Market by Distribution Channel

·         Hospital Pharmacies

·         Retailer Pharmacies

·         Online Pharmacies


Global Parkinson’s Disease Therapeutics Market by End User

·         Hospitals

·         Clinics


Companies Profiled in the Report

·         GSK 

·         Merck 

·         Novartis 

·         Teva

·         Boehringer Ingelheim

·         Impax

·         Abbvie

·         Valeant Pharmaceuticals

·         Lundbeck

·         Sun Pharma


About Infinium Global Research

Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.

Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.